Erratum

Erratum

10.4274/jcrpe.galenos.2021.e002

J Clin Res Pediatr Endocrinol 2021;13(2):249-249 PMID: 34082491

DOI: 10.4274/jcrpe.galenos.2019.2019.0106

Sethi A, Foulds N, Ehtisham S, Ahmed SH, Houghton J, Colclough K, Didi M, Flanagan SE, Senniappan S. Heterozygous Insulin Receptor (INSR) Mutation Associated with Neonatal Hyperinsulinemic Hypoglycaemia and Familial Diabetes Mellitus: Case Series. J Clin Res Pediatr Endocrinol 2020;12:420-426.

The mistake and the correction of the aforementioned article have been demonstrated in the following list:

The mistake has been made inadvertently. The reference cited in the 16th reference of the article is a withdrawn article. By the authors, instead of the 16th reference “Caruso M, Miele C, Oliva A, Condorelli G, Oriente F, Riccardi G, Capaldo B, Fiory F, Accili D, Formisano P, Beguinot F. The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes 2000;49:1194-1202.”, “Eckstein SS, Weigert C, Lehmann R. Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle. Curr Med Chem 2017;24:1827-1852.” has been corrected by citing.

The 16th reference in the manuscript recently:

16. Caruso M, Miele C, Oliva A, Condorelli G, Oriente F, Riccardi G, Capaldo B, Fiory F, Accili D, Formisano P, Beguinot F. The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes 2000;49:1194-1202.

The 16th reference in the manuscript replaced with the prior mentioned:

16. Eckstein SS, Weigert C, Lehmann R. Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle. Curr Med Chem 2017;24:1827-1852.